BUSINESS
Dana-Farber Exits an MGB Medicare Advantage Network Early
MGB will drop Dana-Farber from Medicare Advantage Oct. 1, two years before the split, while Massachusetts still bars health-based Medigap denials.
Mass General Brigham Health Plan will drop Dana-Farber from its Medicare Advantage network on Oct. 1, 2026. The cut lands while the two still share adult cancer care through 2028.
The plan covers about 20,500 members. Local accounts put the Dana-Farber caseload near 1,000 people in treatment. The health plan says the move is about Medicare Advantage finances nationwide, not Boston’s hospital divorce. The letter still arrives while Dana-Farber doctors keep working on the Brigham campus.
The Insurance Cut Landed Before the Hospital Split
Dana-Farber announced in September 2023 that it would leave Brigham and Women’s Hospital, part of Mass General Brigham, and build a new adult inpatient cancer hospital with Beth Israel Deaconess Medical Center. The clinical handoff is scheduled for 2028. The new 300-bed hospital at One Joslin Place is projected to open in 2031.
Beth Israel Deaconess said on April 7, 2026, that deconstruction had started on the old Joslin Diabetes Center building, the first step on a 450,000-square-foot tower with 10 inpatient floors. Until that campus exists, adult patients still get outpatient care at Dana-Farber and inpatient care at the Brigham. Brigham and Women’s Hospital says the two will keep providing collaborative cancer care through 2028.
THE DANA-FARBER REALIGNMENT CLOCK
- September 2023: Dana-Farber announces a clinical collaboration with Beth Israel Deaconess Medical Center and plans for a 300-bed adult cancer hospital.
- April 7, 2026: Beth Israel Deaconess says deconstruction begins at One Joslin Place.
- Oct. 1, 2026: Dana-Farber leaves the Mass General Brigham Medicare Advantage network.
- Oct. 15 to Dec. 7, 2026: Annual Enrollment Period for coverage that starts Jan. 1, 2027.
- 2028: The Dana-Farber and Brigham clinical agreement is scheduled to end.
- 2031: The new inpatient hospital is projected to open.
That is a two-year gap between the insurance letter and the planned end of shared wards. Commercial members on Mass General Brigham Health Plan still have Dana-Farber in network. Only the Medicare Advantage product is being cut.
MGB Blames a National Medicare Advantage Squeeze
Mass General Brigham Health Plan, which operates separately from the hospital system, said the change is “due to the challenging environment impacting Medicare Advantage plans nationwide.” It also said the drop is “unrelated to the ongoing clinical separation and realignment among cancer providers in Boston.”
Medicare Advantage plans across the country have been dropping hospitals and exiting counties as medical costs rise and federal payments tighten. A parent system that also owns an insurer can finish the coverage breakup years before the clinics move, and the first person to feel it is the patient who thought the brand names on the card still matched the building.
Eldon Clingan, an 88-year-old retired accountant in Dedham, has seen the same Dana-Farber specialist for more than two decades and credits her with saving his life. He now has to change oncologists or change plans.
I feel like I am collateral damage in this war.
Eldon Clingan, Dana-Farber patient
“Are they going to cover my medication, for example? This is very expensive medication,” Clingan said. He also said the fight adds anxiety that an 88-year-old with cancer does not need. The plan change was not aimed at him. His calendar still has to absorb it.
Ninety Days, or Until the Treatment Plan Ends
Oct. 1 is not a hard stop for everyone already in care. The health plan says affected members may keep Dana-Farber at in-network rates for 90 days after Oct. 1, or through the end of a defined treatment plan. Those are different clocks. A set course of therapy may run past the 90-day window. Open-ended maintenance may not.
The first call is to the plan, asking which clock applies, and then getting the end date in writing. A verbal “we’ll take care of you” is not a claims rule. After that date, auto-renewal for 2027 leaves Dana-Farber out of network.
Medicare’s Annual Enrollment Period runs Oct. 15 through Dec. 7, 2026, and a plan picked then starts Jan. 1, 2027. Advantage members get a second window, the Medicare Advantage Open Enrollment Period from Jan. 1 through March 31, 2027, but a change made then starts the following month. If the continuity period has already run out, that later switch leaves a gap.
WHAT WE KNOW
- The drop date: Dana-Farber is out of the Mass General Brigham Medicare Advantage network on Oct. 1, 2026.
- Commercial coverage: Dana-Farber remains in the health plan’s commercial network.
- Continuity: In-network Dana-Farber care can continue for 90 days after Oct. 1, or through a defined treatment plan, depending on the member.
- Clean 2027 start: A plan chosen by Dec. 7, 2026, takes effect Jan. 1, 2027.
WHAT IS UNCONFIRMED
- A federal special enrollment period: Medicare.gov says a significant change in a plan’s provider network can create a special enrollment period, evaluated case by case. No public CMS grant for this termination has been posted.
- 2027 directories: Aetna, Blue Cross Blue Shield of Massachusetts, and Tufts Medicare Preferred still list Dana-Farber for the current year. That is not a written promise for Jan. 1, 2027.
- Each patient’s clock: Only the plan can say whether a given case is on the 90-day timer or on a treatment-plan timer.
Call 1-800-MEDICARE and ask whether this termination has been treated as a significant network change. Ask for a reference number. Do not take a sales pitch as the federal answer.
Which Medicare Advantage Plans Still Include Dana-Farber?
Dana-Farber’s insurance page still names four Medicare Advantage products and posts an alert that, effective Oct. 1, 2026, the institute will be no longer in network for that plan run by Mass General Brigham. The other three names on the current list are Aetna Massachusetts Medicare Advantage, Blue Cross Blue Shield of Massachusetts Medicare Advantage, and Tufts Medicare Preferred. Financial counselors at 617-582-9820 can walk through a specific card.
MEDICARE ADVANTAGE PLANS ON DANA-FARBER’S LIST
| Plan | On Dana-Farber’s current list | After Oct. 1, 2026 |
|---|---|---|
| Aetna Massachusetts Medicare Advantage | Yes | Still listed; confirm 2027 in writing |
| Blue Cross Blue Shield of Massachusetts Medicare Advantage | Yes | Still listed; confirm 2027 in writing |
| Tufts Medicare Preferred | Yes | Still listed; confirm 2027 in writing |
| Mass General Brigham Medicare Advantage | Yes, with the Oct. 1 warning | Out of network |
A 2026 directory is a snapshot, not a contract for next year. When you compare plans, name Dana-Farber and name the oncologist, and ask whether both are in network on Jan. 1, 2027. Ask how referrals, prior authorization, and drug coverage work for the regimen you are on. Get a reference number.
Mass General Brigham has already narrowed which Medicare Advantage cards its own primary care groups take, steering a lot of that traffic toward Mass General Brigham Health Plan, Aetna, and Tufts Medicare Preferred. Switching to keep Dana-Farber can collide with keeping an MGB internist. Both have to be checked, not assumed.
Massachusetts Forbids Health-Based Medigap Denials
National Medicare advice treats a return to Original Medicare as a medical-underwriting trap. In most states, dropping Advantage after the first-year trial window lets a supplement insurer decline a person with cancer or price the policy off a health questionnaire. Massachusetts is not most states.
Regulation 211 CMR 71.10 says a Medicare Supplement issuer may not deny a Medigap policy over health status, age, claims, care already received, medical condition, or genetic information. The state also requires an annual open enrollment from Feb. 1 through March 31. KFF, the health-policy research group, counts only four states with this kind of guaranteed-issue shield: Connecticut, Maine, Massachusetts, and New York. KFF has also found that Massachusetts insurers take applications year-round.
Massachusetts does not sell the lettered plans used in national brochures. There is no Plan G here. The standardized products are Core, Supplement 1A for people first eligible in 2020 or later, and Supplement 1 for people eligible earlier. Supplement 1 covers the Part B deductible. Supplement 1A does not, which means the $283 Part B deductible for 2026 stays with the patient on 1A.
A federal special enrollment period would still matter for the timing of an Advantage disenrollment. It is not the only door onto a Massachusetts supplement. Cancer is not a legal basis for a Medigap no in this state. Premiums still vary by product, age, and ZIP code, so the next step is a quote, not a guess.
2026 Cost Sharing Under Original Medicare
Original Medicare plus a Massachusetts supplement is the path that makes Dana-Farber a regular Medicare provider again, with no plan network. It also reopens the public fee schedule. CMS posted the 2026 amounts on Nov. 14, 2025. About 99% of people with Medicare pay no Part A premium. The standard Part B premium is $202.90 a month, up $17.90 from $185.00 in 2025, and the annual Part B deductible is $283, up $26 from $257.
2026 ORIGINAL MEDICARE COST SHARING
| Item | 2026 amount |
|---|---|
| Part B monthly premium | $202.90 |
| Part B annual deductible | $283 |
| Part B coinsurance | 20% of the Medicare-approved amount |
| Part A inpatient deductible, per benefit period | $1,736 |
| Hospital coinsurance, days 61-90 | $434 a day |
| Lifetime reserve days | $868 a day |
| Skilled nursing coinsurance, days 21-100 | $217 a day |
The inpatient hospital deductible of $1,736 is $60 above the 2025 figure of $1,676. Roughly 8% of Part B enrollees also pay an income-related surcharge if modified adjusted gross income is above $109,000 on a single return or $218,000 on a joint return. CMS releases 2027 figures in November. A stand-alone Part D plan is required if you leave an Advantage plan that bundled drugs, because infusions and oral oncology drugs do not pause for paperwork.
A Massachusetts supplement is what turns those deductibles and the 20% coinsurance into a known monthly premium. For a year of infusions, scans, hospital days, and specialist visits, that predictability is the product. Get quotes on Core and Supplement 1A (or Supplement 1, if you were eligible before 2020) rather than using a national Plan G price from the internet.
Auto-Renewal Keeps the Plan and Loses the Institute
Three 2027 paths exist, and doing nothing is one of them. Stay on Mass General Brigham Health Plan and Dana-Farber bills as out of network after the continuity period. Move to another Medicare Advantage plan that still has Dana-Farber, if 2027 network status holds in writing. Or return to Original Medicare, add Part D, and buy a Massachusetts supplement.
Auto-renewal needs no phone call and produces the worst version of a decision. Out-of-network cancer care on an Advantage plan can mean denied claims, full billed charges, or a scramble for a new oncologist in the middle of a protocol. The hospitals are still connected by a pedestrian bridge. The card in the wallet is what changed.
CALLS TO MAKE BEFORE ANNUAL ENROLLMENT
- The continuity date: Ask Mass General Brigham Health Plan whether your case runs 90 days past Oct. 1 or to the end of the treatment plan, and get the date in writing.
- Federal rights: Call 1-800-MEDICARE and ask whether this termination carries a special enrollment period or other exceptional-circumstance relief.
- State counseling: Massachusetts residents can talk with SHINE (Serving the Health Insurance Needs of Everyone) at 800-243-4636 about Advantage, Original Medicare, Part D, and Core or Supplement 1A quotes.
- The 2027 network: If you compare Advantage plans, name Dana-Farber and your oncologist, ask about Jan. 1, 2027, and record the reference number.
- The institute: Dana-Farber financial counselors at 617-582-9820 can check a specific card against the current list and flag partner-hospital billing that sits on a different network.
Annual enrollment opens Oct. 15. Name the institute, name the oncologist, and get the 2027 answer in writing before Dec. 7.
Disclaimer: This article is news reporting and analysis for general information. It is not insurance advice, medical advice, or legal advice, and it is not a recommendation to buy, drop, or keep any Medicare Advantage, Part D, or Massachusetts Medicare Supplement policy. Before you change coverage or interrupt cancer treatment, talk with a licensed Medicare counselor, a SHINE counselor, 1-800-MEDICARE, your plan, and your oncology team about your own benefits and treatment calendar. Premiums, deductibles, network lists, continuity periods, and enrollment rights reflect the official sources cited here and can change as CMS, the plan, and the hospitals update 2026 and 2027 rules.
-
BUSINESS1 month agoWarsh Rejects Rate Guidance and Still Moves Markets
-
NEWS1 month agoNASA Launches the Roman Space Telescope’s Cosmic Bet
-
NEWS1 month agoRussia Recycles Its Old Warning Over Storm Shadow Plants
-
ENTERTAINMENT4 days agoPrimetime’s $2.7 Million Preview Tops Pitt’s Costlier Film
-
BUSINESS1 month agoJet Drones Lock Down Kyiv and Strip Kherson of Heat
-
BUSINESS1 month agoRecord Cyclospora Outbreak Follows Seven Years Without an Inspection
-
NEWS1 month agoOpenAI’s Cyber Letter Puts the Defense Bill on Governments
-
BUSINESS1 month agoIran Pulls Oman Into a Hormuz Revenue Bargain
